UTHR
United Therapeutics Corporation
Drug Manufacturers - Specialty & Generic · Healthcare · United States
593.54
close · 2026-10-29
value
25
cheaper than peers25
quality
76
stronger fundamentals76
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 13.67× | 46 |
| price to book | 3.96× | 41 |
| forward P/E | 17.52× | 33 |
| price to sales | 7.20× | 15 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 42.2% | 91 |
| return on equity | 19.3% | 75 |
| revenue growth | -1.9% | 26 |
3 of 4 measures available
Facts
| market cap | $25B |
| free cash flow | $557.1M |
| employees | 1,400 |
| first trade | 1999-06-17 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 27.86 | 24.64 | 19.81 | 15.00 |
| free cash flow | $1.04B | $1.08B | $747.6M | $663.7M |
| net income | $1.33B | $1.20B | $984.8M | $727.3M |
| revenue | $3.18B | $2.88B | $2.33B | $1.94B |
| unusual items | -$24.7M | -$71.1M | $0 | -$1.7M |